RIGL - Rigel Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$67.00
DETAILS
HIGH:
$85.00
LOW:
$49.00
MEDIAN:
$67.00
CONSENSUS:
$67.00
UPSIDE:
45.75%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Cooperman | 542,539 | $21.2M | 0.0% | +96,861 | INCREASED |
| Greenblatt | 0 | $0 | -- | -- | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-09-02 | Schorno Dean L | officer: EVP & Chief Financial Officer | M-Exempt | 2,000 | $24.20 | $48K |
| 2026-09-01 | Santos David A | officer: EVP, Chief Commercial Officer | F-InKind | 874 | $47.50 | $42K |
| 2026-09-01 | RODRIGUEZ RAUL R | director, officer: CEO, President | F-InKind | 2,424 | $47.50 | $115K |
| 2026-09-01 | Furey Raymond J. | officer: EVP, GC, CCO & Corp Sec | F-InKind | 877 | $47.50 | $42K |
| 2026-09-02 | Schorno Dean L | officer: EVP & Chief Financial Officer | M-Exempt | 1,286 | $24.20 | $31K |
| 2026-09-02 | Schorno Dean L | officer: EVP & Chief Financial Officer | M-Exempt | 694 | $12.70 | $9K |
| 2026-09-01 | Schorno Dean L | officer: EVP & Chief Financial Officer | F-InKind | 928 | $47.50 | $44K |
| 2026-09-02 | Schorno Dean L | officer: EVP & Chief Financial Officer | M-Exempt | 620 | $18.70 | $12K |
| 2026-07-08 | HANNAH ALISON L. | officer: EVP, Chief Medical Officer | A-Award | 24,400 | -- | -- |
| 2026-06-22 | Ali-Jackson Kamil | director | SELL | 2,500 | $35.00 | $88K |
| 2026-06-17 | Rojkjaer Lisa | officer: EVP, Chief Medical Officer | A-Award | 7,394 | $22.49 | $166K |
| 2026-06-17 | Santos David A | officer: EVP, Chief Commercial Officer | A-Award | 7,394 | $22.49 | $166K |
| 2026-06-17 | Rojkjaer Lisa | officer: EVP, Chief Medical Officer | A-Award | 9,375 | $14.90 | $140K |
| 2026-06-17 | Schorno Dean L | officer: EVP & Chief Financial Officer | A-Award | 7,394 | $22.49 | $166K |
| 2026-06-17 | Furey Raymond J. | officer: EVP, GC, CCO & Corp Sec | A-Award | 7,394 | $22.49 | $166K |
| 2026-06-17 | RODRIGUEZ RAUL R | director, officer: CEO, President | A-Award | 31,700 | $22.49 | $713K |
| 2026-06-01 | Schorno Dean L | officer: EVP & Chief Financial Officer | F-InKind | 928 | $29.86 | $28K |
| 2026-06-01 | Santos David A | officer: EVP, Chief Commercial Officer | F-InKind | 874 | $29.86 | $26K |
| 2026-06-01 | RODRIGUEZ RAUL R | director, officer: CEO, President | F-InKind | 2,424 | $29.86 | $72K |
| 2026-06-01 | Rojkjaer Lisa | officer: EVP, Chief Medical Officer | F-InKind | 850 | $29.86 | $25K |
| 2026-06-01 | Schorno Dean L | officer: EVP & Chief Financial Officer | M-Exempt | 1,200 | $18.70 | $22K |
| 2026-06-01 | Schorno Dean L | officer: EVP & Chief Financial Officer | M-Exempt | 2,181 | $12.70 | $28K |
| 2026-06-01 | Furey Raymond J. | officer: EVP, GC, CCO & Corp Sec | F-InKind | 877 | $29.86 | $26K |
| 2026-05-26 | Ali-Jackson Kamil | director | SELL | 2,500 | $29.17 | $73K |
| 2026-05-15 | Frohlich Mark W | director | A-Award | 5,750 | -- | -- |